Literature DB >> 29650554

Pulmonary alveolar proteinosis and Mycobacterium abscessus lung infection related to ruxolitinib after allogeneic stem cell transplantation.

Hélène Salvator1,2,3, Enora Berti1, Emilie Catherinot1, Elisabeth Rivaud1, Alexandre Chabrol1,2, Stephanie Nguyen4, Leila Zemoura5, Emilie Cardot6, Colas Tcherakian1,2,3, Louis-Jean Couderc1,2,3.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29650554     DOI: 10.1183/13993003.01960-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  8 in total

Review 1.  Small airway dysfunction and poor asthma control: a dangerous liaison.

Authors:  Marcello Cottini; Anita Licini; Carlo Lombardi; Diego Bagnasco; Pasquale Comberiati; Alvise Berti
Journal:  Clin Mol Allergy       Date:  2021-05-29

2.  Disseminated Disease by Mycobacterium abscessus and Mycobacterium celatum in an Immunocompromised Host.

Authors:  Maria Elena Locatelli; Salvatore Tosto; Vincenzo D'Agata; Paolo Bonaventura; Rosaria S Grasso; Andrea Marino; Alessio Pampaloni; Daniele Scuderi; Federica Cosentino; Bruno Cacopardo
Journal:  Am J Case Rep       Date:  2020-04-07

3.  Secondary Pulmonary Alveolar Proteinosis Associated with Primary Myelofibrosis and Ruxolitinib Treatment: An Autopsy Case.

Authors:  Hiroyuki Sugiura; Hisakazu Nishimori; Kazuya Nishii; Tomohiro Toji; Keiko Fujii; Nobuharu Fujii; Ken-Ichi Matsuoka; Koh Nakata; Katsuyuki Kiura; Yoshinobu Maeda
Journal:  Intern Med       Date:  2020-05-23       Impact factor: 1.271

Review 4.  Cryptococcal fungemia and Mycobacterium haemophilum cellulitis in a patient receiving ruxolitinib: a case report and literature review.

Authors:  Naruemit Sayabovorn; Piriyaporn Chongtrakool; Methee Chayakulkeeree
Journal:  BMC Infect Dis       Date:  2021-01-07       Impact factor: 3.090

5.  Sirolimus-induced secondary pulmonary alveolar proteinosis.

Authors:  Stephanie Wang; Elinor Lee; Ryan Lau; Tisha Wang
Journal:  Respir Med Case Rep       Date:  2021-12-15

6.  A Disseminated Mycobacterium Abscessus Infection in a Patient Affected by Pulmonary Graft versus Host Disease: Case Report with a Revision of Literature.

Authors:  Andrea Bernardelli; Alberto Schena; Alessia Savoldi; Chiara Colato; Valentina Baretta; Emiliano D'Alessandro; Giulia Zamboni; Mehrdad Shoushtari Zadeh Naseri; Flavio Favaro; Marta Peracchi; Donatella Schena; Angelo Andreini; Simone Cesaro; Cristina Tecchio
Journal:  J Clin Med       Date:  2022-04-25       Impact factor: 4.241

7.  Ruxolitinib inhibits cytokine production by human lung macrophages without impairing phagocytic ability.

Authors:  Nikola Mantov; Mathilde Zrounba; Marion Brollo; S Grassin-Delyle; Matthieu Glorion; Mélanie David; Emmanuel Naline; Philippe Devillier; Hélène Salvator
Journal:  Front Pharmacol       Date:  2022-08-19       Impact factor: 5.988

8.  A TLR2-Activating Fraction From Mycobacterium abscessus Rough Variant Demonstrates Vaccine and Diagnostic Potential.

Authors:  Vincent Le Moigne; Anne-Laure Roux; Aude Jobart-Malfait; Landry Blanc; Karima Chaoui; Odile Burlet-Schiltz; Jean-Louis Gaillard; Stéphane Canaan; Jérôme Nigou; Jean-Louis Herrmann
Journal:  Front Cell Infect Microbiol       Date:  2020-08-27       Impact factor: 5.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.